Free shipping on all orders over $ 500

C25-140

Cat. No. M13561

All AbMole products are for research use only, cannot be used for human consumption.

C25-140 Structure
Size Price Availability Quantity
1mg USD 75 In stock
5mg USD 145 In stock
10mg USD 230 In stock
25mg USD 400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

C25-140, a first-in-class, orally active, and fairly selective TRAF6-Ubc13 inhibitor, directly binds to TRAF6, and blocks the interaction of TRAF6 with Ubc13. C25-140 lowers TRAF6 activity, reduces NF-κB activation, and combats autoimmunity.

Protocol (for reference only)
Cell Experiment
Cell lines H9C2 cells
Preparation method Inhibition of TRAF6 attenuated LPS-mediated myocardial injury. The H9C2 cardiomyocytes were pretreated with C25-140 (5 μM, an inhibitor of TRAF6) for 2 h and then treated with LPS (10 μg/ml) and Deh (10 μg/ml) for 24 h.
Concentrations 2 h
Incubation time 5 μM
Animal Experiment
Animal models Male Kunming mouse
Formulation Not mentioned
Dosages 10 mg/kg
Administration i.p.
Chemical Information
Molecular Weight 457.57
Formula C26H31N7O
CAS Number 1358099-18-9
Solubility (25°C) DMSO 62.5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yadong Li, et al. Front Pharmacol. Dehydrocorydaline Protects Against Sepsis-Induced Myocardial Injury Through Modulating the TRAF6/NF-κB Pathway

[2] Qi Zeng, et al. Int Immunopharmacol. TLR4/TRAF6/NOX2 signaling pathway is involved in ventilation-induced lung injury via endoplasmic reticulum stress in murine model

[3] Jara K Brenke, et al. J Biol Chem. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity

Related TNF Receptor Products
Lenalidomide

Lenalidomide is a thalidomide analog known to display TNF-α secretion inhibition and possesses immunomodulatory properties.

Atrosab

Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody. Atrosab inhibits TNF-mediated Apoptosis induction and IL-6 and IL-8 production. Atrosab reduces neurological deficits.

Infliximab

Infliximab is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that blocks TNF-α interaction with TNF-α receptor 1 (TNFR1) and TNFR2. For the treatment of autoimmune diseases. Infliximab is available in BALB/ C or C57/Bl6 mice.

Mesaconitine

Mesaconitine is the main active ingredient of Aconitum and has many pharmaceutical effects.

Hypaconitine

Hypaconitine is a highly toxic natural active ingredient isolated from aconitum species, which is widely used to study rheumatism.

  Catalog
Abmole Inhibitor Catalog




Keywords: C25-140 supplier, TNF Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.